152 related articles for article (PubMed ID: 15148067)
1. Meta-analysis: respiratory tolerance to regular beta2-agonist use in patients with asthma.
Salpeter SR; Ormiston TM; Salpeter EE
Ann Intern Med; 2004 May; 140(10):802-13. PubMed ID: 15148067
[TBL] [Abstract][Full Text] [Related]
2. Summaries for patients. Tolerance to beta2-agonist treatment after regular use in people with asthma.
Ann Intern Med; 2004 May; 140(10):I41. PubMed ID: 15148090
[No Abstract] [Full Text] [Related]
3. Is the increase in bronchial responsiveness or FEV1 shortly after cessation of beta2-agonists reflecting a real deterioration of the disease in allergic asthmatic patients? A comparison between short-acting and long-acting beta2-agonists.
van Schayck CP; Cloosterman SG; Bijl-Hofland ID; van den Hoogen H; Folgering HT; van Weel C
Respir Med; 2002 Mar; 96(3):155-62. PubMed ID: 11908511
[TBL] [Abstract][Full Text] [Related]
4. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
5. Cardioselective beta-blockers for reversible airway disease.
Salpeter S; Ormiston T; Salpeter E
Cochrane Database Syst Rev; 2002; (1):CD002992. PubMed ID: 11869646
[TBL] [Abstract][Full Text] [Related]
6. Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis.
Salpeter SR; Ormiston TM; Salpeter EE
Ann Intern Med; 2002 Nov; 137(9):715-25. PubMed ID: 12416945
[TBL] [Abstract][Full Text] [Related]
7. Beta₂-agonists for exercise-induced asthma.
Bonini M; Di Mambro C; Calderon MA; Compalati E; Schünemann H; Durham S; Canonica GW
Cochrane Database Syst Rev; 2013 Oct; (10):CD003564. PubMed ID: 24089311
[TBL] [Abstract][Full Text] [Related]
8. Cardioselective beta-blockers for reversible airway disease.
Salpeter S; Ormiston T; Salpeter E
Cochrane Database Syst Rev; 2002; (4):CD002992. PubMed ID: 12519582
[TBL] [Abstract][Full Text] [Related]
9. Cardioselective beta-blocker use in patients with reversible airway disease.
Salpeter S; Ormiston T; Salpeter E
Cochrane Database Syst Rev; 2001; 2002(2):CD002992. PubMed ID: 11406056
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
[TBL] [Abstract][Full Text] [Related]
11. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
Ni CM; Greenstone IR; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
[TBL] [Abstract][Full Text] [Related]
12. Inhaled short acting beta2-agonist use in asthma: regular vs as needed treatment.
Walters EH; Walters J
Cochrane Database Syst Rev; 2000; 2003(4):CD001285. PubMed ID: 11034709
[TBL] [Abstract][Full Text] [Related]
13. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
[TBL] [Abstract][Full Text] [Related]
14. Randomised placebo controlled trial of beta agonist dose reduction in asthma.
Harrison TW; Oborne J; Wilding PJ; Tattersfield AE
Thorax; 1999 Feb; 54(2):98-102. PubMed ID: 10325911
[TBL] [Abstract][Full Text] [Related]
15. Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.
Yates DH; Sussman HS; Shaw MJ; Barnes PJ; Chung KF
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1170-4. PubMed ID: 7551366
[TBL] [Abstract][Full Text] [Related]
16. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
17. A bolus of inhaled budesonide rapidly reverses airway subsensitivity and beta2-adrenoceptor down-regulation after regular inhaled formoterol.
Aziz I; Lipworth BJ
Chest; 1999 Mar; 115(3):623-8. PubMed ID: 10084466
[TBL] [Abstract][Full Text] [Related]
18. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
Yates DH; Worsdell M; Barnes PJ
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
[TBL] [Abstract][Full Text] [Related]
19. Inhaled beclomethasone dipropionate reverts tolerance to the protective effect of salmeterol on allergen challenge.
Giannini D; Bacci E; Dente FL; Di Franco A; Vagaggini B; Testi R; Paggiaro P
Chest; 1999 Mar; 115(3):629-34. PubMed ID: 10084467
[TBL] [Abstract][Full Text] [Related]
20. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.
Taylor DR; Sears MR; Herbison GP; Flannery EM; Print CG; Lake DC; Yates DM; Lucas MK; Li Q
Thorax; 1993 Feb; 48(2):134-8. PubMed ID: 8493626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
